Biomedical Engineering Reference
In-Depth Information
easily measured biomarkers are needed to improve the identification
of patients who will benefit from anti-EGFR moAbs.
References
1. GLOBOCAN 2008 (IARC) Section of Cancer Information accessed
asp?uno=900.
2. Poston GJ, Figueras J, Giuliante F,
Urgent need for a new staging
system in advanced colorectal cancer.
et al.
2008; 26: 4828-
4833. Published on 20080818. doi:10.1200/JCO.2008.17.6453.
J Clin Oncol
3. Markowitz SD, Bertagnolli MM. Molecular origins of cancer: Molecular
basis of colorectal cancer.
N Engl J Med
2009; 361: 2449-2460.
doi:10.1056/NEJMra0804588.
4. Lievre A, Blons H, Laurent-Puig P. Oncogenic mutations as predictive
factors in colorectal cancer.
2010; 29: 3033-3043. Published
on 20100412. doi:10.1038/onc.2010.89.
Oncogene
5. Parsons DW, Wang TL, Samuels Y,
et al.
Colorectal cancer: mutations in
a signalling pathway.
Nature
2005; 436: 792. doi:10.1038/436792a.
6. Ciardiello F, Tortora G. EGFR antagonists in cancer treatment.
N Engl J
Med
2008; 358: 1160-1174. doi:10.1056/NEJMra0707704.
7. Schneider MR, Wolf E. The epidermal growth factor receptor ligands at
a glance.
J Cell Physiol
2009; 218: 460-466. doi:10.1002/jcp.21635.
8. Moroni M, Veronese S, Benvenuti S,
Gene copy number for
epidermal growth factor receptor (EGFR) and clinical response to
antiEGFR treatment in colorectal cancer: a cohort study.
et al.
Lancet Oncol
2005; 6: 279-286. doi:10.1016/S1470-2045(05)70102-9.
9. Barber TD, Vogelstein B, Kinzler KW, Velculescu VE. Somatic mutations
of EGFR in colorectal cancers and glioblastomas.
N Engl J Med
2004;
351: 2883. doi:10.1056/NEJM200412303512724.
10. Samowitz WS, Albertsen H, Herrick J,
Evaluation of a large,
population-based sample supports a CpG island methylator phenotype
in colon cancer.
et al.
Gastroenterology
2005; 129: 837-845. doi:10.1053/j.
gastro.2005.06.020.
11. Samowitz WS, Curtin K, Schaffer D,
Relationship of Ki-ras
mutations in colon cancers to tumor location, stage, and survival: a
population-based study.
et al.
Cancer Epidemiol Biomarkers Prev
2000; 9:
1193-1197.
